[Tumor angiogenesis]

Andréas Bikfalvi1

  • 1Laboratoire des mécanismes moléculaires de l'angiogenèse (Inserm E0113), Université Bordeaux I, avenue des Facultés, 33405 Talence. a.bikfalvi@croissance.u-bordeaux.fr

Bulletin Du Cancer
|July 10, 2003
PubMed

Insights

Tumor angiogenesis, the process of new blood vessel formation in tumors, is crucial for cancer growth and spread. Understanding its molecular control reveals new therapeutic targets for cancer treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cancer Research

Context:

  • Angiogenesis is vital for tumor development and metastasis.
  • Recent research has elucidated the molecular mechanisms regulating angiogenesis.

Purpose:

  • To review recent advances in understanding the molecular control of tumor angiogenesis.
  • To highlight the role of developmental regulators in this process.
  • To identify novel therapeutic targets for cancer therapy.

Summary:

  • Advances in molecular biology have identified numerous ligands, receptors, and signaling molecules involved in angiogenesis.
  • Developmental regulators are now recognized as playing a significant role in tumor angiogenesis.
  • These findings facilitate the development of novel anti-cancer strategies.

Impact:

  • Identified novel therapeutic targets for cancer treatment.
  • Enabled the development of new anti-cancer molecules and therapeutic strategies.
  • Established tumor angiogenesis as a major focus in current cancer research.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...